Optimal administration of dual screening tests for detecting a characteristic with special reference to low prevalence diseases.
暂无分享,去创建一个
[1] Joseph L. Gastwirth,et al. Bayesian analysis of screening data: Application to AIDS in blood donors , 1991 .
[2] Joseph L. Gastwirth,et al. Estimation of the prevalence of a rare disease, preserving the anonymity of the subjects by group testing: application to estimating the prevalence of aids antibodies in blood donors , 1989 .
[3] H. Eggers,et al. Comparison of two commercially available anti‐HIV ELISAs: Abbott HTLV III EIA and Du Pont HTLV III‐ELISA , 1987, Journal of medical virology.
[4] Joseph L. Gastwirth,et al. The Statistical Precision of Medical Screening Procedures: Application to Polygraph and AIDS Antibodies Test Data , 1987 .
[5] Seymour Geisser,et al. [The Statistical Precision of Medical Screening Procedures: Application to Polygraph and AIDS Antibodies Test Data]: Comment , 1987 .
[6] P. Mortimer,et al. Clinical evaluation of Abbott and Wellcome enzyme linked immunosorbent assays for detection of serum antibodies to human immunodeficiency virus (HIV). , 1987, Journal of clinical pathology.
[7] J. Chiavetta,et al. Evaluation of a confidential method of excluding blood donors exposed to human Immunodeficiency virus , 1986, Transfusion.
[8] L. Tierney,et al. Accurate Approximations for Posterior Moments and Marginal Densities , 1986 .
[9] O. Jarrett,et al. A comparison of three methods of feline leukaemia virus diagnosis , 1982, Veterinary Record.
[10] P. Enterline,et al. An evaluation of some commonly used screening tests for heart disease and hypertension. , 1955, Journal of chronic diseases.